CA2459622C - Compositions et methodes pour restaurer la sensibilite aux antagonistes de her2 lors d'un traitement - Google Patents

Compositions et methodes pour restaurer la sensibilite aux antagonistes de her2 lors d'un traitement Download PDF

Info

Publication number
CA2459622C
CA2459622C CA2459622A CA2459622A CA2459622C CA 2459622 C CA2459622 C CA 2459622C CA 2459622 A CA2459622 A CA 2459622A CA 2459622 A CA2459622 A CA 2459622A CA 2459622 C CA2459622 C CA 2459622C
Authority
CA
Canada
Prior art keywords
pcdgf
antagonist
her2
erbb2
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2459622A
Other languages
English (en)
Other versions
CA2459622A1 (fr
Inventor
Ginette Serrero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A&G Pharmaceutical Inc
Original Assignee
A&G Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A&G Pharmaceutical Inc filed Critical A&G Pharmaceutical Inc
Publication of CA2459622A1 publication Critical patent/CA2459622A1/fr
Application granted granted Critical
Publication of CA2459622C publication Critical patent/CA2459622C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2459622A 2003-08-01 2004-02-27 Compositions et methodes pour restaurer la sensibilite aux antagonistes de her2 lors d'un traitement Expired - Fee Related CA2459622C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49153603P 2003-08-01 2003-08-01
US60/491,536 2003-08-01

Publications (2)

Publication Number Publication Date
CA2459622A1 CA2459622A1 (fr) 2005-02-01
CA2459622C true CA2459622C (fr) 2016-12-13

Family

ID=34135125

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2459622A Expired - Fee Related CA2459622C (fr) 2003-08-01 2004-02-27 Compositions et methodes pour restaurer la sensibilite aux antagonistes de her2 lors d'un traitement

Country Status (1)

Country Link
CA (1) CA2459622C (fr)

Also Published As

Publication number Publication date
CA2459622A1 (fr) 2005-02-01

Similar Documents

Publication Publication Date Title
JP6960485B2 (ja) 線維芽増殖因子受容体２に対するモノクローナル抗体
BR112019025188A2 (pt) Anticorpos anti-pdl1 ativáveis e métodos de uso dos mesmos
US9783456B1 (en) Method for inhibiting cell growth using anti-ErbB-3 and anti-ErbB-2 antibodies
TWI432452B (zh) 針對ｈｅｒ-３之抗體類及其用途
TWI630916B (zh) 供治療或預防人表皮生長因子受體－３（ｈｅｒ－３）相關疾病之藥料和方法
Friedländer et al. ErbB-directed immunotherapy: antibodies in current practice and promising new agents
US6927203B1 (en) Treatment of metastatic disease
EP1660010B1 (fr) Compositions et procedes pour le retablissement de la sensibilite au traitement par antagonistes vis-a-vis de her2
US8445219B2 (en) Method of determination of receptor binding saturation effected by monoclonal antibodies
CA2459622C (fr) Compositions et methodes pour restaurer la sensibilite aux antagonistes de her2 lors d'un traitement
KR20240112963A (ko) 대장암을 치료하기 위한 아미반타맙의 용도
EA046745B1 (ru) Способ лечения рака активируемым антителом против pdl1

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20200227